• About
  • FinancialVu Network
  • Register
  • Log In

FinancialVu

Market News and Views

  • Home
  • Commodities
  • Economics
  • Personal Finance
  • Other Articles
  • Reading List
  • Resources
You are here: Home / Archives for MarketWatch.com - Top Stories

Revolution Investing: Stock investors are right to be cautious now, and being bearish is even smarter

April 26, 2023 by MarketWatch.com - Top Stories

Valuations are high and economic turmoil and losses are in the U.S. market’s future, writes Cody Willard.

Filed Under: Top Stories

The Ratings Game: Microsoft worth nearly $150 billion more after stock’s massive Wednesday rally

April 26, 2023 by MarketWatch.com - Top Stories

Microsoft fell short of topping its daily record for market-cap gains, though it still racked up one of the biggest increases on record for a U.S. company.

Filed Under: Top Stories

Economic Report: Mortgage rates rise to highest levels in over a month, but buyers are unfazed

April 26, 2023 by MarketWatch.com - Top Stories

Mortgage applications rose 3.7% in the latest week, the Mortgage Bankers Association said. The average rate for a 30-year mortgage is 6.55%.

Filed Under: Top Stories

: Fans lose out on King Charles III’s Coronation tickets over ‘misleading’ Ticketmaster email

April 26, 2023 by MarketWatch.com - Top Stories

Ticketmaster customers told they’re successful in bagging tickets to King Charles III’s Coronation concert on May 7, only to find out tickets were unavailable.

Filed Under: Top Stories

Real Retirement: ‘I have serious concerns about the process of becoming dead.’ Planning for the death I want.

April 26, 2023 by MarketWatch.com - Top Stories

Filed Under: Top Stories

Need to Know: These are the times when buy-the-dip works — and Wednesday fits the criteria

April 26, 2023 by MarketWatch.com - Top Stories

Buy the dip works, as long as it’s done after a particular criteria is met.

Filed Under: Top Stories

: Biogen wins accelerated FDA approval for treatment for rare form of ALS

April 26, 2023 by MarketWatch.com - Top Stories

The FDA has deemed Biogen’s tofersen reasonably likely to produce a clinical benefit for patients.

Filed Under: Top Stories

The Ratings Game: Tesla stock gets a downgrade: ‘Growing up can be hard to do’

April 26, 2023 by MarketWatch.com - Top Stories

Tesla Inc.’s focus on market share over profit margins has another analyst opting to take a backseat on the stock’s current journey. 

Filed Under: Top Stories

Bond Report: Treasury yields move higher as traders weigh bank sector issues ahead of next week’s Fed decision

April 26, 2023 by MarketWatch.com - Top Stories

Most Treasury rates pull back from declines seen earlier in the day as traders consider the Federal Reserve’s most likely next step.

Filed Under: Top Stories

Outside the Box: Stock market making you nervous? How to control your investing losses.

April 26, 2023 by MarketWatch.com - Top Stories

Memo to investors: You will lose money

Filed Under: Top Stories

  • « Previous Page
  • 1
  • …
  • 750
  • 751
  • 752
  • 753
  • 754
  • …
  • 1275
  • Next Page »

Recent Articles

Starboard may be poised to build value amicably at contract research firm Fortrea

Activist Starboard Value recently disclosed a position in Fortrea Holdings. The … [Read More...]

  • High rates are historically bad for bitcoin. Here’s what’s in store for crypto with the 10-year near 5%
  • Stocks like Nvidia have ‘earnings upside’ ahead of quarterly reports, Wall Street analysts say
  • Israel-Hamas war live updates: First aid trucks enter Gaza from Egypt; Palestinian leader says ‘we will remain on our land’

Follow Us Online

  • Twitter

Copyright © 2026 · News Pro Theme on Genesis Framework · WordPress · Log in